Your browser doesn't support javascript.
loading
Impact of the presence of heart disease, cardiovascular medications and cardiac events on outcome in COVID-19.
Cabezón Villalba, Gonzalo; Amat-Santos, Ignacio J; Dueñas, Carlos; Lopez Otero, Diego; Catala, Pablo; Aparisi, Alvaro; López-Pais, Javier; Cacho Antonio, Carla Eugenia; Candela, Jordi; Antúnez Muiños, Pablo; Gil, Jose Francisco; Gonzalez Ferrero, Teba; Marcos, Marta; Pérez-Poza, Marta; Rojas, Gino; Otero Garcia, Oscar; Veras, Carlos; Jiménez Ramos, Victor; Uribarri, Aitor; Revilla, Ana; Garcia-Granja, Pablo Elpidio; Gómez, Itziar; González-Juanatey, José Ramón; San Román, J Alberto.
Afiliación
  • Cabezón Villalba G; Department of Cardiology, Institute of Heart Sciences (ICICOR), Hospital Clínico Universitario, Valladolid, Spain.
  • Amat-Santos IJ; Department of Cardiology, Institute of Heart Sciences (ICICOR), Hospital Clínico Universitario, Valladolid, Spain.
  • Dueñas C; Hospital Clínico Universitario de Valladolid, Valladolid, Spain.
  • Lopez Otero D; Complejo Hospitalario Universitario de Santiago de Compostela, Rua da Choupana s/n, 15702 Santiago de Compostela, Spain.
  • Catala P; Department of Cardiology, Institute of Heart Sciences (ICICOR), Hospital Clínico Universitario, Valladolid, Spain.
  • Aparisi A; Department of Cardiology, Institute of Heart Sciences (ICICOR), Hospital Clínico Universitario, Valladolid, Spain.
  • López-Pais J; Complejo Hospitalario Universitario de Santiago de Compostela, Rua da Choupana s/n, 15702 Santiago de Compostela, Spain.
  • Cacho Antonio CE; Complejo Hospitalario Universitario de Santiago de Compostela, Rua da Choupana s/n, 15702 Santiago de Compostela, Spain.
  • Candela J; Department of Cardiology, Institute of Heart Sciences (ICICOR), Hospital Clínico Universitario, Valladolid, Spain.
  • Antúnez Muiños P; Complejo Hospitalario Universitario de Santiago de Compostela, Rua da Choupana s/n, 15702 Santiago de Compostela, Spain.
  • Gil JF; Department of Cardiology, Institute of Heart Sciences (ICICOR), Hospital Clínico Universitario, Valladolid, Spain.
  • Gonzalez Ferrero T; Complejo Hospitalario Universitario de Santiago de Compostela, Rua da Choupana s/n, 15702 Santiago de Compostela, Spain.
  • Marcos M; Department of Cardiology, Institute of Heart Sciences (ICICOR), Hospital Clínico Universitario, Valladolid, Spain.
  • Pérez-Poza M; Complejo Hospitalario Universitario de Santiago de Compostela, Rua da Choupana s/n, 15702 Santiago de Compostela, Spain.
  • Rojas G; Department of Cardiology, Institute of Heart Sciences (ICICOR), Hospital Clínico Universitario, Valladolid, Spain.
  • Otero Garcia O; Complejo Hospitalario Universitario de Santiago de Compostela, Rua da Choupana s/n, 15702 Santiago de Compostela, Spain.
  • Veras C; Department of Cardiology, Institute of Heart Sciences (ICICOR), Hospital Clínico Universitario, Valladolid, Spain.
  • Jiménez Ramos V; Complejo Hospitalario Universitario de Santiago de Compostela, Rua da Choupana s/n, 15702 Santiago de Compostela, Spain.
  • Uribarri A; Department of Cardiology, Institute of Heart Sciences (ICICOR), Hospital Clínico Universitario, Valladolid, Spain.
  • Revilla A; Department of Cardiology, Institute of Heart Sciences (ICICOR), Hospital Clínico Universitario, Valladolid, Spain.
  • Garcia-Granja PE; Department of Cardiology, Institute of Heart Sciences (ICICOR), Hospital Clínico Universitario, Valladolid, Spain.
  • Gómez I; Department of Cardiology, Institute of Heart Sciences (ICICOR), Hospital Clínico Universitario, Valladolid, Spain.
  • González-Juanatey JR; Complejo Hospitalario Universitario de Santiago de Compostela, Rua da Choupana s/n, 15702 Santiago de Compostela, Spain.
  • San Román JA; Department of Cardiology, Institute of Heart Sciences (ICICOR), Hospital Clínico Universitario, Valladolid, Spain. asanroman@secardiologia.es.
Cardiol J ; 28(3): 360-368, 2021.
Article en En | MEDLINE | ID: mdl-33843043

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Fármacos Cardiovasculares / Pandemias / COVID-19 / Cardiopatías Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: Cardiol J Año: 2021 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Fármacos Cardiovasculares / Pandemias / COVID-19 / Cardiopatías Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: Cardiol J Año: 2021 Tipo del documento: Article País de afiliación: España